RecruitingNot ApplicableNCT04691986

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans


Sponsor

VA Office of Research and Development

Enrollment

144 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Frailty is an age-associated clinical condition of poor physiological reserve that increases risks for falls, hospitalization and mortality. Nicotinamide adenine dinucleotide (NAD) is a critical co-factor needed for many cellular processes. The natural levels of NAD decline aging and this has been linked to physical performance decline in animals. Human trials have demonstrated that nicotinamide riboside (NR), a form of vitamin B3, is safe and effectively increases NAD+ levels. In animal studies, NR improves treadmill performance and muscle quality. Here the investigators propose a double-blind randomized control trial to assess the benefits of NR supplementation on human muscle function and physiology. The investigators anticipate the research findings will support the use of this nutritional supplement to improve the health of Veterans during aging.


Eligibility

Min Age: 65 YearsMax Age: 85 Years

Inclusion Criteria5

  • Ages 65-85
  • Male or female
  • Any race
  • Ability to use an exercise bike
  • Medically cleared for muscle biopsy

Exclusion Criteria7

  • Severe Co-morbidity
  • examples include, but not limited to:
  • congestive heart failure class equal to or above III
  • chronic obstructive pulmonary disorder (COPD) gold stage IV
  • chronic kidney disease equal to or above stage
  • A VA-SLUMS cognitive screen score of less than or equal to 20
  • Body mass index greater than or equal to 40

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTNicotinamide Riboside

Nicotinamide Riboside is a form of vitamin B3 and is naturally occurring in humans.

OTHERPlacebo

Placebo pills contain micro cellulose powder.


Locations(1)

Kansas City VA Medical Center, Kansas City, MO

Kansas City, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04691986


Related Trials